EP1940883A2 - Composition contenant un derive d'oxyde d'alkylene de pectine - Google Patents

Composition contenant un derive d'oxyde d'alkylene de pectine

Info

Publication number
EP1940883A2
EP1940883A2 EP06826673A EP06826673A EP1940883A2 EP 1940883 A2 EP1940883 A2 EP 1940883A2 EP 06826673 A EP06826673 A EP 06826673A EP 06826673 A EP06826673 A EP 06826673A EP 1940883 A2 EP1940883 A2 EP 1940883A2
Authority
EP
European Patent Office
Prior art keywords
pectin
skin
alkylene oxide
controlling composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06826673A
Other languages
German (de)
English (en)
Inventor
Jens Skil Trudsoe
Jan Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CP Kelco US Inc
Original Assignee
CP Kelco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CP Kelco US Inc filed Critical CP Kelco US Inc
Publication of EP1940883A2 publication Critical patent/EP1940883A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Definitions

  • Pectin is a complex polysaccharide associated with plant cell walls, with the middle lamella layer of the cell wall the richest in pectin. Pectins are produced and deposited during cell wall growth and are particularly abundant in soft plant tissues under conditions of fast growth and high moisture content.
  • Pectin consists of an alpha 1-4 linked polygalacturonic acid backbone intervened by rhamnose residues and modified with neutral sugar side chains and non- sugar components such as acetyl, methyl, and ferulic acid groups.
  • the neutral sugar side chains which include arabinan and arabinogalactans, are attached to the rhamnose residues in the backbone.
  • the rhamnose residues tend to cluster together on the backbone.
  • pectins are partly esterified and present as the methyl ester.
  • the degree of esterification is defined as the percentage of carboxyl groups esterified.
  • Pectin with a degree of esterification ("DE") above 50% is named high methyl ester (“HM”) pectin or high ester pectin and one with a DE lower than 50% is referred to as low methyl ester (“LM”) pectin or low ester pectin.
  • DE degree of esterification
  • HM high methyl ester
  • LM low methyl ester
  • Pectins are most stable at pH 3-4. Below pH 3, methoxyl and acetyl groups and neutral sugar side chains are removed.
  • Pectin is a weak acid, and is less soluble at low pH than at high pH.
  • a pectin having lower or higher solubility is provided.
  • the pH is typically increased through the use of bases such as alkali metal hydroxides or alkali metal carbonates, but other bases are equally useable.
  • bases such as alkali metal hydroxides or alkali metal carbonates, but other bases are equally useable.
  • sodium carbonate sodium pectinate is formed and the higher the dosage of sodium carbonate and, thus, the higher the pH, the more of the carboxylic acids are transformed to their sodium salts.
  • the pectin starts to de-esterify during pH-adjustment, handling and storage.
  • the pH should be maintained at a level at or below pH 6.
  • pectin has mainly been used as a gelling agent for jam or similar, fruit-containing, or fruit-flavoured, sugar-rich systems. Examples are traditional jams, jams with reduced sugar content, clear jellies, fruit-flavoured confectionery gels, non-fruit-flavoured confectionery gels, heat-reversible glazing for the bakery industry, heat-resistant jams for the bakery industry, ripples for use in ice cream, and fruit preparations for yoghurt. A substantial portion of pectin is used today for stabilization of low-pH milk drinks, including fermented drinks and mixtures of fruit juice and milk.
  • Pectin and other polysaccharides have also been proposed for possible use in personal care compositions and household products, such as skin cremes and lotions.
  • Patents and other publications describing the role of pectin in such compositions are set forth in greater detail in Danish Patent Application No. PA2004/00649, now also PCT Patent Application DK2005/000285, which is hereby incorporated by reference.
  • skin cremes that treat skin irritation and provide skin protection.
  • Skin has a protective layer on its surface called the "acid mantle” that is a mixture of sebum and sweat which are excreted by sebaceous glands and sweat glands located throughout the dermal layer of skin, just below its surface.
  • the acid mantle In addition to helping protect skin from "the elements" (such as wind or pollutants), the acid mantle also inhibits the growth of harmful bacteria and fungi. If the acid mantle is disrupted or loses its acidity, the skin becomes more prone to damage and infection.
  • the loss of acid mantle is one of the side effects of washing the skin with soaps or detergents of moderate or high strength as upon washing with soap, a pH of 8-10 is established in the wash liquor. This alkalinity neutralizes the natural acid mantle of the skin (pH 5-6). Although in normal skin this acid mantle is reformed relatively quickly, in sensitive or pre-damaged skin irritations may result.
  • a further disadvantage of soaps is the formation of insoluble lime soaps in hard water.
  • soap Being alkaline, soap emulsifies the oily layer covering the natural horny layer (stratum corneum) of a person's skin and neutralizes a likewise natural acid mantle of the epidermis, which has, normally, an acid pH of approximately 5.5-6.5. Failure to readily regenerate the acid and oily part of the epidermis—particularly among older people—often results in dermatological symptoms, such as itching, chapping and cracking of the epidermis, especially in cold weather. Of course, always to be considered is that significant segment of the population, which is allergic to or cannot tolerate conventional soaps in view of a number of reactions (sensitivities) resulting from the use thereof.
  • a need for a composition remains, which is capable of providing buffering, thus avoiding a major increase in the pH of an aqueous system and/or useable for reducing the pH of aqueous systems, in which alkalinity is formed as a result of chemical and/or biological reactions, or as a result of alkalinity being imposed on the aqueous system by the environment.
  • a composition which will protect the acid mantle, and there is a need for incorporating such a composition in articles, which are in contact with the skin, either human skin or animal skin.
  • the present invention relates to a skin-protecting alkalinity-controlling composition comprising an alkylene oxide derivative of pectin having a degree of esterification in the range from about 30% to about 100%.
  • the present invention also relates to a skin-protecting alkalinity- controlling composition comprising: (1) about 0.1% to about 2% of an alkylene oxide derivative of pectin having a degree of esterification (DE) in the range from about 30% to about 100%, and a DPGE of about 5% to about 100%; and (2) a low DE carboxylic acid polysaccharide having a degree of esterification in the range from about 5% to about 70%.
  • DE degree of esterification
  • Figure 1 shows the alkali consumption of propylene glycol pectins of different degrees of esterification
  • Figure 2 shows the alkali consumption of propylene glycol pectins having different starting degrees of esterification
  • Figure 3 shows the pH-drop of propylene glycol pectins of different degrees of esterification
  • Figure 4 shows the pH-drop of the propylene glycol pectins of Figure 3 having a 75% DE, but having different starting degrees of esterification
  • Figure 5 shows the pH drop of the propylene glycol pectins having a
  • Figure 6 shows the pH drop of the propylene glycol pectin solutions prepared by dissolution at 25°C and 70 0 C
  • Figure 7 shows the effect of propylene glycol pectin concentration on pH drop (using a pH drop index),
  • Figure 8 shows the effect of dissolution temperature and multiple alkali additions on pH drop
  • Figure 9 shows the identical results to Figure 8, but using a normalized pH-drop index
  • Figure 10 shows the comparative alkali consumption of three different materials, methyl pectin, propylene glycol pectin (as described in the present invention), and propylene glycol alignate,
  • Figure 11 5 shows shows the comparative pH-drop performance of three different materials, methyl pectin, propylene glycol pectin (as described in the present invention), and propylene glycol alignate.
  • the skin-protecting alkalinity-controlling composition according to the invention comprises a high DE alkylene oxide derivative of pectin, which can be applied to the skin of humans or animals.
  • Uses include but are not limited to lotions, creams, foundations, face masks, hair care products, genital lotions, deodorants, ostomy products, feminine hygiene products, laundry products, bath salt products, soap products, fragrance products, lotionized tissue products, and shaving products. Further, such pectin can be used in similar products to treat animals.
  • alkylene oxide derivatives of pectin prepared according to the present invention provides a higher level of alkali consumption than methylated pectin at a similar total degree of esterification. Similarly there is a clear superiority of alkali consumption between an alkylene oxide derivative of pectin and propylene glycol alginate, with the alkylene oxide derivative of pectin providing a significantly higher level of alkali consumption.
  • the other carboxylic acid polysaccharides can be more effective at reducing pH than an alkylene oxide derivative of pectin.
  • Propylene glycol alginate is more effective in reducing pH than methylated pectin, which in turn is more effective than an alkylene oxide derivative of pectin.
  • alkylene oxide derivatives of pectin still provide superior performance because it is possible to achieve higher degrees of esterification than what is possible using conventional techniques for producing methylated pectin.
  • alkylene oxide derivatives of pectin having a total degree of esterification of above 90% is both easily achievable and provides more effective pH reducing performance conventionally produced methylated pectin having a degree of esterification of about 70%.
  • the alkylene oxide derivatives of pectin prepared according to the present invention will have a high degree of esterification ("DE").
  • DE degree of esterification
  • the DE will be in the range of from about 30% to about 100%, more preferably from about 80% to about 100%.
  • Alkylene oxide derivatives of pectin are produced as a reaction of an alkylene oxide and pectin. This method is described in greater detail in U.S. Patent No. 2,522,970 issued on September 19, 1950 to Steiner et al., hereby incorporated by reference.
  • the alkylene glycol has its oxygen coupled to adjacent carbon atoms, or to carbon atoms separated by only a single position as for example, epoxyethane; 1,2 or 1,3 epoxypropane; 1,2 1,3 or 2,3 epoxybutane; etc. See U.S. Patent No. 2,426,125 issued August 19, 1947 to Steiner et al., hereby incorporated by reference.
  • the skin-protecting alkalinity-controlling composition according to the invention comprises a high DE alkylene oxide derivative of pectin, which can be applied to the skin of humans or animals. Uses include but are not limited to lotions, creams, foundations, face masks, hair care products, genital lotions, deodorants, ostomy products, feminine hygiene products, laundry products, bath salt products, soap products, fragrance products, lotionized tissue products, and shaving products. Further, such pectin can be used in similar products to treat animals.
  • the alkylene oxide derivatives of pectin prepared according to the present invention provide a higher level of alkali consumption than methylated pectin at a similar total degree of esterification. Similarly there is a clear superiority of alkali consumption between alkylene oxide derivatives of pectin and propylene glycol alginate, with alkylene oxide derivatives of pectin providing a significantly higher level of alkali consumption.
  • the other carboxylic acid polysaccharides can be more effective at reducing pH than alkylene oxide derivatives of pectin.
  • Propylene glycol alginate is more effective in reducing pH than methylated pectin, which in turn is more effective than alkylene oxide derivatives of pectin.
  • alkylene oxide derivatives of pectin still provide superior performance because it is possible to achieve higher degrees of esterification than what is possible using conventional techniques for producing methylated pectin.
  • alkylene oxide derivatives of pectin having a total degree of esterification of above 90% is both easily achievable and provides more effective pH reducing performance conventionally produced methylated pectin having a degree of esterification of about 70%.
  • the alkylene oxide derivatives of pectin prepared according to the present invention will have a high degree of esterif ⁇ cation ("DE").
  • DE esterif ⁇ cation
  • the DE will be in the range of from about 30% to about 100%, more preferably from about 80% to about 100%.
  • DPGE propylene glycol esterif ⁇ cation
  • the DPGE should be relatively low, between about 5% and about 100%, preferably between about 10% and about 90%, more preferably between about 30% and about 90%, even more preferably between about 70% and about 90%.
  • the skin- protecting alkalinity controlling composition further comprises at least one low DE- carboxylic acid polysaccharide having a degree of esterif ⁇ cation (DE) in the range from about 5 to about 70 %, more preferably from about 5 to about 40 %, most preferably from 10 to about 35 %.
  • DE esterif ⁇ cation
  • a carboxylic acid polysaccharide having a relatively low DE provides for a large alkali consumption capacity or buffer capacity.
  • An advantage of a higher buffer capacity is the ability of the pectin to neutralize an initial high concentration of alkali. This is an advantage particularly when fabrics are insufficiently depleted for alkaline washing powder.
  • an initial alkali consumption buffering can be obtained succeeded by a pH-reduction.
  • the high DE alkylene oxide derivatives of pectin may also be supplemented by one or more additional high DE carboxylic acid polysaccharides.
  • the additional high DE carboxylic acid polysaccharides and low DE carboxylic acid polysaccharides may be selected from the group comprising pectin esters, alginic acid esters, esterif ⁇ ed cellulose ethers, esterified hydroxyethylcellulose, esterified carboxymethylcellulose, esterified guar gum, esterified cationic guar gum, esterified hydrocypropyl guar gum, starch esters, and polymerized sugar esters.
  • any of said additional high DE carboxylic acid polysaccharides and said low DE carboxylic acid polysaccharides is a pectin ester, preferably a pectin ester of aliphatic, arylaliphatic, cycloaliphatic or heterocyclic alcohols, more preferably an ester of methanol, ethanol, propanol or isopropanol, and most preferably an ester of methanol.
  • any of the additional high DE carboxylic acid polysaccharides, and the low DE carboxylic acid polysaccharides is a pectin having a molecular weight in the range from about 5,000 to about 140,000, preferably in the range from about 10,000 to about 125,000, most preferably in the range from about 10,000 to about 40,000.
  • any of said esterified alginic acids is an alginic acid ester of aliphatic, aromatic, araliphatic, alicyclic and heterocyclic alcohols, including esters deriving from substituted alcohols such as esters of bivalent aliphatic alcohols, preferably ethylene glycol or propylene glycol alginate.
  • esters deriving from substituted alcohols such as esters of bivalent aliphatic alcohols, preferably ethylene glycol or propylene glycol alginate.
  • US 5,416,205 discloses suitable alginic acid derivatives, and the reference is enclosed herewith in its entirety.
  • the skin-protecting, alkalinity-controlling compositions according to the invention are particularly suitable for use in personal care products.
  • said products are for use on human skin.
  • said products are for use on animal skin.
  • the alkylene oxide derivative of pectin is present in a concentration of about 0.1% to about 2% ( more preferably in a concentration of about 0.1% to about 1%) of the skin-protecting, alkalinity-controlling compositions.
  • the skin protecting alkalinity-controlling composition is used in a product selected from the group consisting of skin creams, skin lotions, deodorant products, fragrance products, hair care products, shaving products, soap products, and bath salt products.
  • the skin protecting alkalinity-controlling composition is used in a product selected from the group consisting of female hygiene products and diapers.
  • a particular advantage of the present composition is the fact that they are capable of controlling the alkalinity of the surface, to which they are applied, for a prolonged time.
  • the carboxylic acid polysaccharides are capable of controlling the alkalinity at multiple challenges of alkalinity. This fact can be utilized in e.g. deodorant products, diapers or female hygiene products, which are repeatedly exposed to sweat that is decomposed by microorganisms to alkaline substances. Thus, a prolonged effective alkalinity control may be obtained by the products according to the present invention.
  • the skin-protecting alkalinity-controlling composition is used in a product selected from the group consisting of ostomy products and wound care products.
  • a low solubility polysaccharide such as a low solubility pectin
  • a low solubility pectin should be used, since the ostomy product should remain insoluble for a longer period of time during flushing by body fluids.
  • a combination of a low DE and a low pH pectin would provide for a longer durability of the ostomy product during use.
  • the skin- protecting alkalinity-controlling composition is used in a product selected from the group consisting of lotionized tissue products, fabric treating products, and laundry rinse products.
  • a product selected from the group consisting of lotionized tissue products, fabric treating products, and laundry rinse products.
  • the following experimental materials and methods were used in carrying out the present experiments.
  • Determination of degree of esterification (DE) and galacturonic acid (GA) in non-amide pectin was selected from the group consisting of lotionized tissue products, fabric treating products, and laundry rinse products.
  • This method pertains to the determination of % DE and % GA in pectin, which does not contain amide and acetate ester.
  • Test tube Drying cabinet at 105 0 C
  • Blind test Double determination is carried out: 1. Titrate 100 ml carbon dioxide-free or deionized (same type as used for the sample) water to pH 8.5 with 0.1 N NaOH (1-2 drops).
  • pectin was dissolved in 200 g. deionized water at 7O 0 C and at 2O 0 C. 2. The solution was placed in a thermostatically controlled water bath at 25°C and continuously stirred.
  • the sample from reaction 1 has a DPGE of 10.7; the sample from reaction 3 has a DPGE of 40.2; the sample from reaction 6 has a DPGE of 67.3.
  • Figure 2 it appears that at equal total degrees of esterification, the alkali consumption increases with decreasing degree of propylene glycol esterification.
  • Example 2 Ability to Reduce pH [0068] Portions of the same seven samples were then evaluated for their ability to reduce pH in a pH drop measurement. The pH drop was measured by the following experimental procedure:
  • Figure 4 is a detail of figure 3, showing the pH drop curves for three samples from reactions 1, 3, and 6. AU of these samples had propylene glycol pectin of about the same DE (about 75%), but each of these samples was prepared from pectin material having differents DEs. As can be seen in Figure 4, all of these samples have near identical pH drop performance as shown by the near-overlapping curves in Figure 4. This indicates that the pH-drop is independent of the original degree of methylation of the starting pectin product.
  • a sample of the propylene glycol pectin produced in reaction 5 was run through three additions of alkali. First, the pH was raised to about 10. After one hour at 30 - 32 0 C, the pH was once more increased to about 10, and after an additional hour at 30 - 32°C, the pH was raised to about 10 for a third time and the sample left at 30 - 32°C for yet one hour. Two seperate tests were run. In one set, the propylene glycol pectin was dissolved in deionized water at 25°C (step 1 of the "Procedure for Determining the pH-drop") and in another the dissolution temperature was set to 70°C. The results are set forth in Table 7, below.
  • propylene glycol pectin prepared according to the present invention provides a higher level of alkali consumption than methylated pectin at similar total degree of esterification. Similarly there is a clear superior of alkali consumption between propylene glycol pectin and propylene glycol alginate, with propylene glycol pectin providing a significantly higher level of alkali consumption. [0089] However, as can be seen in Table 9 and Figure 11, propylene glycol alginate is more effective in reducing pH than methylated pectin, which in turn is more effective than propylene glycol pectin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition de régulation de l'alcalinité pour la protection cutanée contenant un dérivé de pectine d'oxyde d'alkylène qui présente un degré d'estérification compris entre environ 30 % et environ 100 %.
EP06826673A 2005-10-27 2006-10-26 Composition contenant un derive d'oxyde d'alkylene de pectine Withdrawn EP1940883A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/260,530 US20070098870A1 (en) 2005-10-27 2005-10-27 Composition containing alkylene oxide derivative of pectin
PCT/US2006/041683 WO2007050711A2 (fr) 2005-10-27 2006-10-26 Composition contenant un derive d'oxyde d'alkylene de pectine

Publications (1)

Publication Number Publication Date
EP1940883A2 true EP1940883A2 (fr) 2008-07-09

Family

ID=37968534

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06826673A Withdrawn EP1940883A2 (fr) 2005-10-27 2006-10-26 Composition contenant un derive d'oxyde d'alkylene de pectine

Country Status (7)

Country Link
US (1) US20070098870A1 (fr)
EP (1) EP1940883A2 (fr)
JP (1) JP2009513652A (fr)
CN (1) CN101296946A (fr)
AR (1) AR056593A1 (fr)
TW (1) TW200800277A (fr)
WO (1) WO2007050711A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060468A1 (es) * 2004-04-26 2006-07-06 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad de la piel que comprende polisacaridos de acido carboxilico
US8685420B2 (en) 2012-03-02 2014-04-01 Cp Kelco Aps Personal care compositions with acidified pectins

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132065A (en) * 1938-10-04 Pectate and method of making same
US1634879A (en) * 1925-12-23 1927-07-05 Nanji Dinshaw Rattonji Manufacture of pectin products
US2253389A (en) * 1938-07-12 1941-08-19 Speas Company Jelly and manufacture thereof
US2375376A (en) * 1944-03-31 1945-05-08 Maclay William Dayton Method of extracting pectinous materials
US2426125A (en) * 1944-04-03 1947-08-19 Kelco Co Manufacture of glycol alginates
US2478170A (en) * 1945-03-07 1949-08-09 Maclay William Dayton Low-methoxyl pectins and process for their preparation
US2522970A (en) * 1946-06-15 1950-09-19 Kelco Co Manufacture of glycol pectates and pectinates
US2552970A (en) * 1949-10-22 1951-05-15 Sonic Res Corp Sonic generator
US3982003A (en) * 1974-09-04 1976-09-21 Mars Limited Gelling and thickening agents
GB2050825B (en) * 1979-06-14 1983-07-27 Kanebo Ltd Creamy or milky skin cosmetic compositions
US4335025A (en) * 1980-02-19 1982-06-15 Witco Chemical Corporation Process for the preparation of synthetic detergent bars, and products produced thereby
US4831127A (en) * 1983-07-12 1989-05-16 Sbp, Inc. Parenchymal cell cellulose and related materials
JPS60215620A (ja) * 1984-04-12 1985-10-29 Kao Corp 弱酸性入浴剤
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
US4813942A (en) * 1987-03-17 1989-03-21 Bioderm, Inc. Three step wound treatment method and dressing therefor
US4761279A (en) * 1987-03-31 1988-08-02 Eastman Kodak Company Shaving cream formulations
DE9218563U1 (de) * 1991-05-24 1994-09-29 Technica Entwicklungsgesellschaft mbH & Co KG, 23909 Ratzeburg Anordnung zur CO¶2¶-Feinstimprägnierung von Wasser
IT1264321B (it) * 1992-01-13 1996-09-23 Mini Ricerca Scient Tecnolog Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie
US5567462A (en) * 1992-02-06 1996-10-22 Sanofi Bio-Industries, Inc. Pecto-cellulosic product from whole citrus peel and other materials
US5378468A (en) * 1992-09-22 1995-01-03 The Mennen Company Composition containing body activated fragrance for contacting the skin and method of use
FR2701396B1 (fr) * 1993-02-12 1995-04-21 Oreal Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées.
US5403612A (en) * 1993-03-31 1995-04-04 Humanetics Corporation Process for producing a phosphorylated pectin-containing fiber product
US5354851A (en) * 1993-03-31 1994-10-11 Humanetics Corporation Process for producing crude pectin through ion exchange
US5656734A (en) * 1995-10-30 1997-08-12 Systems Bio-Industries Methods for making pectin and pectocellulosic products
JP2757252B2 (ja) * 1995-11-27 1998-05-25 工業技術院長 重合性糖エステル及びその製造方法
FR2745980B1 (fr) * 1996-03-15 1998-06-05 Utilisation de pectines depolymerisees d'agrumes et de pommes a titre d'agents emulsifiants et stabilisants d'emulsions
US5837254A (en) * 1996-11-14 1998-11-17 Chen; Yu Method of treating candida and cryptococcus fungal infections by administering gentian
FI107386B (fi) * 1996-12-31 2001-07-31 Valtion Teknillinen Menetelmä tärkkelysesterien valmistamiseksi
US6013618A (en) * 1997-04-24 2000-01-11 Procter & Gamble Company Perfumes having odor longevity benefits
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US5972321A (en) * 1998-06-30 1999-10-26 Akpharma Inc. Acid neutralization of skin
EP1171566B1 (fr) * 1999-04-20 2004-12-22 The Procter & Gamble Company Precurseurs de parfum
US6352700B1 (en) * 1999-05-03 2002-03-05 Fort James Corporation Lotionized tissue products containing a pH balance compound for the skin
US6528643B1 (en) * 2000-05-05 2003-03-04 Hercules Incorporated Esterified polysaccharide products and B-lactone ring opened ketene dimer products containing the compositions, and process of making the same
US6428837B1 (en) * 2000-06-09 2002-08-06 Cp Kelco Aps Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same
DE10035213A1 (de) * 2000-07-20 2002-01-31 Beiersdorf Ag Geformtes Seifenprodukt, enthaltend Talkum, eine oder mehrere Fettsäuren in Form ihrer Alkaliseifen und eine oder mehrere rückfettend wirkende Substanzen bei gleichzeitiger Abwesenheit von Alkyl-(oligo)-glycosiden
CN1224378C (zh) * 2001-05-10 2005-10-26 宝洁公司 护肤组合物
US6509311B1 (en) * 2001-08-28 2003-01-21 Isp Investments Inc. Propylene glycol alginate gels
US6887508B2 (en) * 2002-02-20 2005-05-03 Solae, Llc Protein stabilizing agent
PE20060468A1 (es) * 2004-04-26 2006-07-06 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad de la piel que comprende polisacaridos de acido carboxilico
US20070092622A1 (en) * 2005-10-25 2007-04-26 Trudsoe Jens E Composition containing pectin ester

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007050711A2 *

Also Published As

Publication number Publication date
WO2007050711A3 (fr) 2007-07-05
JP2009513652A (ja) 2009-04-02
TW200800277A (en) 2008-01-01
AR056593A1 (es) 2007-10-10
US20070098870A1 (en) 2007-05-03
WO2007050711A2 (fr) 2007-05-03
CN101296946A (zh) 2008-10-29

Similar Documents

Publication Publication Date Title
US20150038458A1 (en) Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof
DK2532685T3 (en) The polymer hydrogels and the use thereof
EP2110121B1 (fr) Compositions cosmétiques et dermatologiques, en particulier pour le traitement de substrats contenant de la kératine
RU2336280C2 (ru) Улучшенный способ обработки растительного материала, содержащего пектин
CN109010243A (zh) 一种保湿精华液
GB2500817A (en) Low endotoxin chitosan
US20070092622A1 (en) Composition containing pectin ester
US20070098870A1 (en) Composition containing alkylene oxide derivative of pectin
CN107915850A (zh) 含硒壳聚糖水凝胶及其制备、降解方法和应用
WO2024154815A1 (fr) Composition aqueuse, agent anti-inflammatoire, agent hydratant, composition alimentaire pour anti-inflammation ou hydratation, et procédé de production de composition aqueuse
CN110274901A (zh) 一种便携式甲醇显色试纸及其制备方法
AU2013204055B2 (en) Polymer hydrogels and methods of preparation thereof
JPH08283306A (ja) 水溶性部分脱アセチル化キチン及びその製造法
JPH04282306A (ja) カルボキシメチル化多糖塩を含有する化粧料
CN1312118A (zh) 一种海绵状止血材料的制备方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080328

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503